Can't believe it has taken the industry this long to announce another M&A!
In the current state of affairs in the Pharmaceutical sector, growth by M&A appears to be the trend. With so many changes happening before, during and after a M&A, how does one maintain their own identity and company culture? Or does one just simply aim to create a new one?
“This powerful combination brings together leading technology and analytics with deep scientific expertise delivered on a global scale by our 50,000 immensely talented professionals in more than 100 markets,” said Ari Bousbib, chairman and chief executive of IMS Health. “Our combined business will accelerate growth, yield greater operating efficiencies and provide more flexibility for future expansion.”